CTLT Oct 2024 55.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
At close: 09:45AM EDT
Loading interactive chart…
- Zacks
Catalent's (CTLT) Latest Partnership to Boost Clinical Trials
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
- Zacks
Catalent (CTLT) Q3 Earnings Lag Estimates, Gross Margin Up
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
- GuruFocus.com
Decoding Catalent Inc (CTLT): A Strategic SWOT Insight
Insightful Analysis of Catalent Inc's Strengths, Weaknesses, Opportunities, and Threats
© 2024 Yahoo. All rights reserved.